LifeMD(US:LFMD) Globenewswire·2025-09-10 19:52Core Viewpoint - The Gross Law Firm is notifying shareholders of LifeMD, Inc. regarding a class action lawsuit due to alleged misleading statements and failure to disclose critical information during a specified class period [1][3]. Group 1: Allegations - The complaint alleges that LifeMD's management materially overstated the company's competitive position [3]. - It is claimed that the defendants were reckless in raising LifeMD's 2025 guidance without properly accounting for rising customer acquisition costs in the RexMD segment and related to obesity treatment drugs like Wegovy and Zepbound [3]. - As a result, the statements made by the defendants regarding LifeMD's business, operations, and prospects were materially false and misleading [3]. Group 2: Class Action Details - The class period for the lawsuit is defined as May 7, 2025, to August 5, 2025 [3]. - Shareholders are encouraged to register for the class action by the deadline of October 25, 2025, to potentially be appointed as lead plaintiffs [4]. - Participation in the case does not incur any cost or obligation for the shareholders [4]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect the rights of investors who have suffered due to deceit, fraud, and illegal business practices [5]. - The firm is committed to ensuring companies adhere to responsible business practices and engage in good corporate citizenship [5]. - The firm seeks recovery for investors who experienced losses due to false or misleading statements that led to artificial inflation of the company's stock [5].